http://en.people.cn/n3/2025/0226/c90000-20281641.html

China’s brain-computer interface (BCI) sector has witnessed a series of policy initiatives aimed at accelerating the development of the BCI industry chain. On Tuesday, the National Medical Products Administration (NMPA) announced the approval of new industry standards for medical devices with BCI technology, referring to communication and control channels for direct interaction between the human brain and external devices.

In recent years, BCI technology has gradually been applied in fields such as healthcare, industrial safety, education, sports, and smart lifestyles. With the aging of the population and the increasing number of patients with neurological disorders, BCI technology is increasingly in demand in the fields of healthcare and rehabilitation, and BCI to enhance the quality of life among healthy people is also on the rise.For example, products like wearable BCI devices and BCI-enabled intelligent robots for rehabilitation are being developed to address conditions like strokes, spinal cord injuries and dementia.

Since the beginning of 2025, tech departments in cities like Beijing and Shanghai have been actively releasing action plans for the development of BCI technology, focusing on regulatory policies, clinical trials and industrial chain development.

China’s commitment to leveraging policy support and market forces to expand the application scenarios of BCI points to China as a key player in the global BCI market.